Free Trial
ASX:IMU

Imugene (IMU) Stock Price, News & Analysis

Imugene logo

About Imugene Stock (ASX:IMU)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
12.70 million shs
Average Volume
N/A
Market Capitalization
A$290.84 million
P/E Ratio
N/A
Dividend Yield
3.03%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imugene and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMU Stock News Headlines

Imugene Expands Market Presence with New Securities Quotation
REVEALED: Something Big Happening Behind White House Doors
What I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.tc pixel
See More Headlines

IMU Stock Analysis - Frequently Asked Questions

Imugene Limited (ASX:IMU) released its quarterly earnings data on Thursday, February, 28th. The company reported $0.00 earnings per share (EPS) for the quarter. Imugene had a negative trailing twelve-month return on equity of 95.62% and a negative net margin of 1,855.22%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Imugene investors own include Meta Platforms (META), NVIDIA (NVDA), Precision BioSciences (DTIL), Fortescue (FMG), Teladoc Health (TDOC), Viralytics (VRACY) and Whitehaven Coal (WHC).

Company Calendar

Last Earnings
2/28/2019
Today
10/13/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
ASX:IMU
CIK
N/A
Fax
N/A
Employees
110
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$149.68 million
Net Margins
-1,855.22%
Pretax Margin
N/A
Return on Equity
-95.62%
Return on Assets
-50.88%

Debt

Debt-to-Equity Ratio
1.31
Current Ratio
3.86
Quick Ratio
15.17

Sales & Book Value

Annual Sales
A$4.97 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
3.75
Book Value
A$0.02 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
7,570,000,000
Free Float
N/A
Market Cap
A$290.84 million
Optionable
Not Optionable
Beta
3.34
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (ASX:IMU) was last updated on 10/14/2025 by MarketBeat.com Staff
From Our Partners